← brief for 2026-08-14 · Nutrition & lifestyle

Optimizing hyperkalemia management in CKD: real-world nephrologist strategies and impact on patient outcomes.

Article B Peer reviewed Small trial

Key takeaways

Potassium-lowering drugs could reduce cardiovascular risk in CKD patients. The study had 429 patients over 3 years.

Who did this work

Marques M · López-Sánchez P · Morales E · Bajo MA · Rodriguez A · Fernández Lucas M · Paraiso V · Bucalo L · Hernandez Y · De La Flor JC · Padrón M · Bouarich H

Source

Article · PubMed, Nutritional supplements and CKD · 2026 Aug 14
https://pubmed.ncbi.nlm.nih.gov/42599085/